Key facts
- cliexa’s last known valuation is $12.0M (Jul 2021).
- It has raised $9.5M across 1 recorded rounds; the latest was Seed Round ($3.3M) in May 2025.
- Notable investors include Village Capital, Endless Frontier Labs, Mayo Clinic Platform, Colorado Office of Economic Development & International Trade, American College of Cardiology Foundation — 13 tracked in total.
- cliexa has filed 1 Form D with the SEC, most recently Feb 2026 ($3.3M sold to 19 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for cliexa
Funding rounds
1 roundsAbout cliexa
Developer of an end-to-end virtual health platform designed to improve clinical care and outcomes while maximizing reimbursements. The company's platform leverages patient-reported data to support clinically validated assessment models and incorporates patient-reported data into systems that clear pathways for clinicians to check their patients while increasing quality and compliance, enabling patients to track their chronic disease activity with scientifically tested scoring models.
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2015
- Employees
- 23
- Website
- cliexa.com/
- Ownership
- Privately Held (backing)
cliexa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in cliexa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on cliexa in its N-PORT filings yet. We sweep new filings monthly.